NCT01149473View on ClinicalTrials.gov

Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions

Healthy

Interventions

DRUG

Losartan potassium/Hydrochlorothiazide

100/25 mg Tablets

DRUG

Losartan potassium/Hydrochlorothiazide

100/25 mg Tablets

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

All Listed Sponsors

lead

Teva Pharmaceuticals USA

INDUSTRY

NCT01149473 - Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions | Biotech Hunter | Biotech Hunter